DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 11:45:52 2024-06-27 EDT | ||
| 1.95 EUR | -0.51% |
|
| Current month | +7.10% | ||
| 1 month | +5.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 1.95 | -0.51% |
| 24-06-26 | 1.96 | -1.51% |
| 24-06-25 | 1.99 | +1.53% |
| 24-06-24 | 1.96 | +2.62% |
| 24-06-21 | 1.91 | +1.60% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 11:45 am
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC7KRZ |
| ISIN | DE000HC7KRZ3 |
| Date issued | 2023-06-22 |
| Strike | 250 $ |
| Maturity | 2024-12-18 (174 Days) |
| Parity | 10 : 1 |
| Emission price | 0.87 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2 € |
|---|---|
| Lowest since issue | 0.71 € |
| Spread | 0.01 € |
| Spread % | 0.51% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.16%
- Stock Market
- Certificates
- Certificat
